New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023
August 04, 2022 06:00 ET | Prestige Consumer Healthcare Inc.
Revenue of $277.1 Million in Q1 fiscal 2023 increased 2.9% versus Prior YearDiluted EPS of $1.09 for Q1, ahead of expectationsNet Cash Provided by Operating Activities of $58.2 Million and Non-GAAP...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results
July 11, 2022 16:30 ET | Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 11, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 first quarter earnings release on Thursday, August...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022
May 05, 2022 16:30 ET | Prestige Consumer Healthcare Inc.
Company Exceeds Full-Year Earnings Outlook for Revenue, EPS, and Cash FlowRevenue of $266.9 Million in Q4 and $1,086.8 Million for Full-Year Fiscal 2022, up 12.3% and 15.2% versus Prior Year,...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results
February 03, 2022 06:00 ET | Prestige Consumer Healthcare Inc.
Revenue of $274.5 Million in Q3, up 14.9% versus Prior Year, up 8.8% on an Organic BasisDiluted EPS of $0.99 in Q3, up 22.2% versus Prior YearNon-GAAP Free Cash Flow of $64.1 Million for Third Quarter...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results
January 10, 2022 16:30 ET | Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 third quarter earnings release on Thursday,...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results
November 04, 2021 06:00 ET | Prestige Consumer Healthcare Inc.
Record revenue of $276.2 Million in Q2, up 16.3% versus Prior Year, up 10.5% on an Organic BasisDiluted EPS of $0.89 and Adjusted Diluted EPS of $1.02 in Q2, up 30.8% versus Prior YearNet Cash...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results
October 06, 2021 16:30 ET | Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 second quarter earnings release on Thursday,...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 First Quarter Results
August 05, 2021 06:00 ET | Prestige Consumer Healthcare Inc.
Revenue was $269.2 Million in Q1, up 17.3% versus Prior YearRecord Diluted EPS of $1.14 in Q1, up 32.5% versus Prior YearNet Cash Provided by Operating Activities of $69.3 million and Free Cash Flow...
New Prestige Consumer Healthcare Logo.jpg
Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date
July 01, 2021 16:01 ET | Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige“ or the “Company”) today announced that it has completed the previously announced...
New Prestige Consumer Healthcare Logo.jpg
Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears
May 27, 2021 08:30 ET | Prestige Consumer Healthcare Inc.
Acquisition adds TheraTears brand to Company’s leading eye care portfolioAcquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basisTransaction...